This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
What You Should Know: – Exo , a health information and devices company, today has announced it has acquired Medo, an FDA-cleared AI platform that makes ultrasound workflow faster, more reliable, and accessible to all. .
Earlier last year, the FDA issued an emergency use authorization (EUA) for monoclonal antibody treatments bringing additional needs for infusion treatments in many alternate care settings. Similar to 2020, there were increases in demand in 2021 for infusion pumps to treat COVID-19 patients. New Infusion Data Will Optimize Care.
To the Federal Drug Administration to report adverse events and track FDA-regulated products. For example, in Georgia, medical professionals are required by OCGA §31-7-9 to report any non-accidental patient injuries. To personal representatives of adult patients and unemancipated minor patients.
Accused Of Filing False Claims Settles For $14.7M governor pushes new Medicaid expansion proposal with work requirement Missouri state senator wants voters to have say in KU Health System, Liberty Hospital merger Kansas ACLU request to halt excessive wait times at Larned turned down by judge ‘Who cares about us?
FDA expands use of Pfizer vaccine, green-lights boosters for children 12-15. HHS: Protections against surprise medical bills implemented at dawn of new year. More Military MedicalPersonnel Are Assisting Hospitals With Covid-19 Treatment As Staff Shortages Mount. COVID-19 hospitalizations up in 34 states.
Ends Idaho Abortion Law Row After Mutual Dismissal Saint Alphonsus CEO shares about state of health care, need for medicalpersonnel in Idaho St. Sarah Huckabee Sanders Announces Appointments More med residents could bring Arkansas a $465M boost – Axios NW Arkansas UAMS Receives $2.5M
The core premise of Bexis’ article is very simple: Once the FDA has said “yes” and approved a particular drug for a particular indication (“intended use”) for sale in the United States, federal preemption precludes any state from saying say “no” and trying to ban that same FDA-approved drug. T]he growing market for mifepristone. . .
The prescriber] provided explicit, uncontroverted testimony that, even when provided with the most current research and FDA mandated warnings, as well as the information found in [defendant’s] updated. . . 2001) (no causation where medicalpersonnel “had no alternative other than to use the. . . 3d 1223, 1233 (11th Cir.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content